Outcomes of Patients Not Responding to Antibiotics in the Community

NCT00245427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2007-10-31

No results posted yet for this study

Summary

A study to report the outcomes of patients who fail to respond to beta-lactam and macrolide antibiotics in the community

Conditions

  • Sinusitis
  • Bronchitis, Chronic
  • Pneumonia, Bacterial

Interventions

DRUG

all macrolide antibiotics

Varies based on antibiotic

DRUG

all beta-lactam antibiotics

Varies based on antibiotic

Sponsors & Collaborators

  • Sanofi

    collaborator INDUSTRY
  • CPL Associates

    lead OTHER

Principal Investigators

  • Jerome J Schentag, Pharm.D. · State University of NY at Buffalo

  • Joseph Paladino, Pharm.D. · State University of NY at Buffalo

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2006-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245427 on ClinicalTrials.gov